Cancer: Breakthrough Pain
Also known as: Cancer Related Pain (Breakthrough Pain) / Breakthrough Cancer Pain / Breakthrough cancer pain (finding) / Breakthrough pain (finding) / Breakthrough pain
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00813 | Fentanyl | An opioid analgesic used in anesthesia, for breakthrough cancer pain, or round the clock pain management. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00813 | Fentanyl | Mu-type opioid receptor | target |
| DB00813 | Fentanyl | Delta-type opioid receptor | target |
| DB00813 | Fentanyl | Cytochrome P450 3A4 | enzyme |
| DB00813 | Fentanyl | Cytochrome P450 3A7 | enzyme |
| DB00813 | Fentanyl | P-glycoprotein 1 | transporter |
| DB00813 | Fentanyl | Kappa-type opioid receptor | target |
| DB00813 | Fentanyl | P-glycoprotein 1 | target |
| DB00813 | Fentanyl | Serum albumin | carrier |
| DB00813 | Fentanyl | alpha1-acid glycoprotein | carrier |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00813 | Fentanyl | 1 / 2 | Not Yet Recruiting | 1 |
| DB00327 | Hydromorphone | 2 | Recruiting | 1 |
| DB00295 | Morphine | 2 | Recruiting | 1 |
| DB00497 | Oxycodone | 2 | Recruiting | 1 |
| DB00813 | Fentanyl | 3 | Completed | 1 |
| DB00813 | Fentanyl | 3 | Unknown Status | 1 |
| DB05564 | Fentanyl | 3 | Unknown Status | 1 |
| DB00327 | Hydromorphone | 3 | Unknown Status | 1 |
| DB01221 | Ketamine | 3 | Terminated | 1 |
| DB00295 | Morphine | 3 | Terminated | 1 |
| DB00295 | Morphine | 3 | Unknown Status | 1 |
| DB00497 | Oxycodone | 3 | Unknown Status | 1 |
| DB00921 | Buprenorphine | Not Available | Completed | 1 |
| DB00813 | Fentanyl | Not Available | Completed | 4 |
| DB00813 | Fentanyl | Not Available | Unknown Status | 2 |
| DB00327 | Hydromorphone | Not Available | Completed | 1 |
| DB00333 | Methadone | Not Available | Completed | 1 |
| DB00295 | Morphine | Not Available | Completed | 1 |
| DB00497 | Oxycodone | Not Available | Completed | 1 |
| DB06204 | Tapentadol | Not Available | Completed | 1 |